vaccine using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins
AstraZeneca buys US vaccine company in $1.1bn deal: Britain’s biggest drugmaker buying Seattle-based firm Icosavax, expanding vaccine and immune therapy business
theguardian.com/business/2023/dec/12/astrazeneca-buys-us-vaccine-company-icosavax-seattle
Quick Glance: AstraZeneca's Acquisition of US Vaccine Company in $1.1 Billion Deal
- AstraZeneca is acquiring a Seattle-based company, Icosavax, working on a potential vaccine for two common respiratory diseases.
- The US company's main vaccine targets respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), causing severe illnesses in adults over 60 and those with chronic conditions.
- In intermediate studies, the vaccine demonstrated strong immune responses against RSV and hMPV one month post-vaccination.
- It is a combination protein VLP vaccine given as a single dose.
Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close
cbc.ca/news/canada/montreal/medicago-closing-governments-seek-outside-buyer-1.6736129
Quebec-based COVID-19 vaccine maker Medicago to shut down: A year ago, Medicago's plant-based COVID-19 vaccine, Covifenz, was approved by Health Canada and ...
cbc.ca/news/canada/montreal/covid-vaccine-maker-medicago-shuts-down-1.6735521
Medicago COVID-19 vaccine manufacturing plant to shut down in Quebec: Mitsubishi Chemical said it had decided against commerically producing the Covifenz vaccine ...
nationalpost.com/news/canada/medicago-covid-19-vaccine-manufacturing-plant-to-shut-down-in-quebec
Big Tobacco's divestment from Quebec's Medicago 'a step in the right direction' for its COVID vaccine
cbc.ca/news/health/philips-morris-divestment-medicago-1.6700103
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics